Skip to content

Observational study on Invasive Pneumococcal Disease (IPD) in Indian Children participants

Surveillance of Invasive Pneumococcal Disease (IPD) in Indian Children: A Multicentric, Ambispective, Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/10/096159
Enrollment
202
Registered
2025-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A403- Sepsis due to Streptococcus pneumoniae

Interventions

Intervention1: Nil: Nil

Sponsors

Abbott India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Male or female less than 18 years of age at enrollment in the pediatric departments of study sites • Diagnosis of invasive pneumococcal disease (IPD), defined as isolation of Streptococcus pneumoniae on culture or detection of pneumococcal DNA by PCR from a normally sterile body site based on the clinical syndrome • For participants enrolled retrospectively: Availability of details of demographic characteristics, clinical symptoms, comorbidities, and disease progression from diagnosis to study enrollment, with a focus on the duration of illness, severity, and complications (the disease course will be captured until hospital discharge or until recovery). • For participants enrolled retrospectively: Availability of archived isolates and clinical data • For participants enrolled prospectively: Willingness to provide written informed consent by parent/legally authorized representative (LAR) and assent by participants greater than and equal to 7 years of age

Exclusion criteria

Exclusion criteria: • Patients with incomplete medical records and non-availability of adequate biological samples as per the Investigator’s discretion

Design outcomes

Primary

MeasureTime frame
Serotype distribution of S. pneumoniae in participantsTimepoint: Baseline

Secondary

MeasureTime frame
Serotype distribution of S. pneumoniae in participants stratified by age groupTimepoint: Baseline;Incidence of spectrum of IPD and clinical complications (pneumonia, meningitis, septicemia, and others) among participants stratified by serotype of S. pneumoniae isolate(s)Timepoint: Baseline;Antimicrobial susceptibility of S. pneumoniae isolates stratified by serotypeTimepoint: Baseline;Proportion of participants with and without pneumococcal vaccinationTimepoint: Baseline;Serotype distribution of S. pneumoniae in participants stratified by vaccination status (vaccinated vs. nonvaccinated)Timepoint: Baseline;Spectrum of IPD and clinical complications (pneumonia, meningitis, septicemia, and others) in participants stratified by vaccination status (vaccinated vs. nonvaccinated)Timepoint: Baseline;Severity of IPD based on requirement of intensive care and/or ventilation support in participants stratified by vaccination status (vaccinated vs. nonvaccinated)Timepoint: Baseline

Countries

India

Contacts

Public ContactDr Monjori Mitra

Institute of Child Health

monjorimr@gmail.com9831075734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026